The organization says its particularly interested in applicants with knowledge of health systems, interest in emerging technologies such as AI, as well as Indigenous perspectives.
In addition to their effects on type 2 diabetes, weight loss and colorectal cancer risk, glucagon-like peptide-1 receptor analogues may also act on nine other obesity-related cancers, reports a new study.
Much of the focus for proactive treatments for patients with diabetes has been on type 2 diabetes. But what can be done for patients at risk of developing type 1 diabetes?
